Niagen Bioscience, Inc. NAGE
Updated: 9 Aug 2026
No signal published yet
We already track Niagen Bioscience and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Niagen Bioscience, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Niagen Bioscience free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 6, 2026, Niagen Bioscience announced the launch of its Tru Niagen product line on Walmart.com to expand its e-commerce market presence. On August 4, 2026, the company reported second-quarter 2026 net sales of $29.8 million alongside operational updates on its Niagen Plus telehealth platform and therapeutic candidate NB4168. The company closed the quarter with $66.7 million in cash and cash equivalents and no outstanding debt.
What Firelda Watch includes for Niagen Bioscience, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Niagen Bioscience, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Niagen Bioscience free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more